Board of Directors

Mission Therapeutics has an experienced Board of Directors.

Dr Colin Goddard

Non-Executive Chairman

Colin Goddard serves on the board of several public and private Biotechnology companies and is Executive Chairman of Coferon, Inc. and Merganser Biotech Inc. From October 1998, until its $4 billion acquisition…


Dr Michael Moore

Non-Executive Deputy Chairman

Michael Moore holds PhD and DSc degrees from the University of Nottingham and is a Fellow of the Royal College of Pathologists. He has had an extensive academic research career and retains the post of Professor…


Dr Anker Lundemose

Chief Executive Officer

Anker Lundemose, MD, PhD, DMSc in Medical Microbiology, has extensive experience from business and corporate development as well as R&D in key therapeutic areas including oncology, diabetes and anti-infectives…


Professor Steve Jackson

Chief Scientific Officer

After graduating in biochemistry from the University of Leeds followed by a PhD from Edinburgh University, Steve carried out post-doctoral training in the lab of Professor Robert Tjian at Berkeley, USA. In 1991, he became a…


Graziano Seghezzi

Partner, Sofinnova Partners

Graziano Seghezzi is a Partner at Sofinnova Partners which he joined in 2006. He seeded and was on the Board of GlycoVaxyn which was sold to GlaxoSmithKline in 2015 and Omthera Pharmaceuticals…


Rob Woodman

Director, Touchstone Innovations

Rob Woodman is Director of Healthcare Investments at Touchstone Innovations, and currently serves on the board of Mission Therapeutics, Stanmore Implants, and Nascient Therapeutics. Rob joined Innovations…


Elaine Jones

Executive Director, Pfizer Venture Investments

Elaine V. Jones, Ph.D. joined Pfizer Venture Investments as Executive Director, Venture Capital in 2008. She is responsible for making and managing venture investments for Pfizer and currently manages the …


Deborah Harland

Partner, SR One

Deborah Harland joined SR One in 2005 to establish the firm’s European investment office. She has extensive operational, drug development and licensing experience gained in numerous clinical development…


Dr. Carole Nuechterlein

Head Roche Venture Fund

Carole Nuechterlein has headed the Roche Venture Fund since 2001. Prior to her current position, she worked in the pharmaceutical/biotech industry as an attorney for ten years. She joined Roche from SangStat…


Gabriella Camboni

Non-Executive Director

Through 2013 Maria Gabriella Camboni MD, was Chief Operating Officer of EOS, a start-up company devoted to translational research in oncology that she co-founded with Silvano Spinelli in 2006; in 2013 EOS was sold…